Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation.

The FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Volumn 17, Issue 8, 2003, Pages 944-946

  Delgado, Mario ^a   Ganea, Doina ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; MESSENGER RNA; NEUROPROTECTIVE AGENT; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL; ARTICLE; CELL CULTURE; CELL DEATH; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; GLIA; INTOXICATION; MESENCEPHALON; METABOLISM; MOUSE; NERVE CELL;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; 1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; CELL DEATH; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE AGENTS; GENE EXPRESSION REGULATION; INTERLEUKIN-1; MESENCEPHALON; MICE; MPTP POISONING; NEUROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; VASOACTIVE INTESTINAL PEPTIDE;

MLCS; MLOWN;

EID: 0038322494     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.02-0799fje     Document Type: Article

References (0)